Evidence map›Paper›PMID 29046393›Full record

ArticleThe Biochemical journal2017

Rac1-stimulated macropinocytosis enhances Gβγ activation of PI3Kβ.

Zahra Erami, Bassem D Khalil, Gilbert Salloum, Yanhua Yao, Jaclyn LoPiccolo, Aliaksei Shymanets, Bernd Nürnberg, Anne R Bresnick, Jonathan M Backer

Abstract read
In one paragraph

Article in The Biochemical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer.Frontiers in cell and developmental biology · 2020
    Article
  9. Combined mTORC1/mTORC2 inhibition blocks growth and induces catastrophic macropinocytosis in cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  10. Article
  11. Review
  12. The origins and evolution of macropinocytosis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  13. Article
  14. Article
  15. Macropinocytosis, mTORC1 and cellular growth control.Cellular and molecular life sciences : CMLS · 2018
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Zahra EramiDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.
Bassem D KhalilDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.
Gilbert SalloumDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.
Yanhua YaoDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.
Jaclyn LoPiccoloDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, U.S.A.
Aliaksei ShymanetsDepartment of Pharmacology and Experimental Therapy, Institute for Pharmacology and Toxicology and Interfaculty Center of Pharmacogenomics and Pharma Research, Eberhard-Karls-Universität Tübingen, Tubingen, Germany.
Bernd NürnbergDepartment of Pharmacology and Experimental Therapy, Institute for Pharmacology and Toxicology and Interfaculty Center of Pharmacogenomics and Pharma Research, Eberhard-Karls-Universität Tübingen, Tubingen, Germany.
Anne R BresnickDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, U.S.A. jonathan.backer@einstein.yu.edu anne.bresnick@einstein.yu.edu.
Jonathan M BackerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, U.S.A. jonathan.backer@einstein.yu.edu anne.bresnick@einstein.yu.edu.
Albert Einstein College of Medicine · USUniversity of Tübingen · DE

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
Tumor Progression and MetastasisP01CA100324 · NCI · YESHIVA UNIVERSITY · PI CONDEELIS, JOHN S · 2003 to 2018
$30.0M
Special Animal CoreP30DK041296 · NIDDK · YESHIVA UNIVERSITY · PI WOLKOFF, ALLAN W · 1989 to 2018
$22.9M
Regulation of the Class IA PI 3-kinase PIK3CBR01GM112524 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BACKER, JONATHAN M., BRESNICK, ANNE R · 2014 to 2017
$1.6M
The Role of PI3K Beta in Breast Cancer MetastasisR01GM119279 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BACKER, JONATHAN M., BRESNICK, ANNE R · 2016 to 2019
$1.5M
NCI NIH HHS P01 CA100324NCI NIH HHS P30 CA013330NIDDK NIH HHS P30 DK041296NIGMS NIH HHS R01 GM112524NIGMS NIH HHS R01 GM119279NIGMS NIH HHS T32 GM007288
6 · The paper itself

Abstract

Phosphoinositide 3-kinases (PI 3-kinases) are regulated by a diverse range of upstream activators, including receptor tyrosine kinases (RTKs), G-protein-coupled receptors (GPCRs), and small GTPases from the Ras, Rho and Rab families. For the Class IA PI 3-kinase PI3Kβ, two mechanisms for GPCR-mediated regulation have been described: direct binding of Gβγ subunits to the C2-helical domain linker of p110β, and Dock180/Elmo1-mediated activation of Rac1, which binds to the Ras-Binding Domain of p110β. We now show that the integration of these dual pathways is unexpectedly complex. In breast cancer cells, expression of constitutively activated Rac1 (CA-Rac1) along with either GPCR stimulation or expression of Gβγ led to an additive PI3Kβ-dependent activation of Akt. Whereas CA-Rac1-mediated activation of Akt was blocked in cells expressing a mutated PI3Kβ that cannot bind Gβγ, Gβγ and GPCR-mediated activation of Akt was preserved when Rac1 binding to PI3Kβ was blocked. Surprisingly, PI3Kβ-dependent CA-Rac1 signaling to Akt was still seen in cells expressing a mutant p110β that cannot bind Rac1. Instead of directly binding to PI3Kβ, CA-Rac1 acts by enhancing Gβγ coupling to PI3Kβ, as CA-Rac1-mediated Akt activation was blocked by inhibitors of Gβγ. Cells expressing CA-Rac1 exhibited a robust induction of macropinocytosis, and inhibitors of macropinocytosis blocked the activation of Akt by CA-Rac1 or lysophosphatidic acid. Our data suggest that Rac1 can potentiate the activation of PI3Kβ by GPCRs through an indirect mechanism, by driving the formation of macropinosomes that serve as signaling platforms for Gβγ coupling to PI3Kβ.

Indexed as

Adaptor Proteins, Signal TransducingCell Line, TumorClass Ia Phosphatidylinositol 3-KinaseEnzyme ActivationGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsHEK293 CellsHumansLysophospholipidsPinocytosisProtein BindingProto-Oncogene Proteins c-aktrac1 GTP-Binding Proteinrac GTP-Binding ProteinsSignal TransductionAdaptor Proteins, Signal TransducingClass Ia Phosphatidylinositol 3-KinaseDOCK1 protein, humanELMO1 protein, humanGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma Subunitslysophosphatidic acidLysophospholipidsProto-Oncogene Proteins c-aktrac1 GTP-Binding ProteinRAC1 protein, humanrac GTP-Binding Proteinsbreast cancersG-protein-coupled receptorsmacropinocytosisphosphoinositide 3-kinaseRac

Identifiers

PMID29046393
PMCPMC5858185
OpenAlexW2766829325

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.